Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Alexion Pharmaceuticals, Inc.    ALXN

Delayed Quote. Delayed  - 09/28 06:53:18 pm
124.63 USD   -1.07%
09/23 ALEXION PHARMAC : Employees Volunteer Together in Company’s Fi..
09/13 ALEXION PHARMAC : Launches Uncommon Strength Campaign to Unite and C..
09/06 ALEXION PHARMAC : to Present at Upcoming Investor Conferences
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
09/22/2016 09/23/2016 09/26/2016 09/27/2016 09/28/2016 Date
133.69(c) 127.22(c) 124.51(c) 125.98(c) 124.63 Last
1 175 594 2 154 637 1 484 700 1 350 927 723 961 Volume
+2.55% -4.84% -2.13% +1.18% -1.07% Change
More quotes
Financials ($)
Sales 2016 3 074 M
EBIT 2016 1 285 M
Net income 2016 541 M
Debt 2016 1 866 M
Yield 2016 -
Sales 2017 3 637 M
EBIT 2017 1 627 M
Net income 2017 897 M
Debt 2017 1 244 M
Yield 2017 -
P/E ratio 2016 52,64
P/E ratio 2017 32,84
EV / Sales2016 9,80x
EV / Sales2017 8,11x
Capitalization 28 251 M
More Financials
Company
Alexion Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on serving patients with devastating and ultra-rare disorders through the innovation, development and commercialization of life-transforming therapeutic products.Its products include soliris, strensiq and kanuma.The company... 
Sector
Pharmaceuticals
Calendar
09/28 | 05:35pmPresentation
More about the company
Surperformance© ratings of Alexion Pharmaceuticals, I
Trading Rating : Investor Rating :
More Ratings
Latest news on ALEXION PHARMACEUTICALS, I
09/23 ALEXION PHARMACEUTICALS : Employees Volunteer Together in Company’s First ..
09/22 ALEXION PHARMACEUTICALS INC : Change in Directors or Principal Officers, Financi..
09/13 ALEXION PHARMACEUTICALS : Launches Uncommon Strength Campaign to Unite and Celeb..
09/06 ALEXION PHARMACEUTICALS : to Present at Upcoming Investor Conferences
08/29 ALEXION PHARMACEUTICALS : European Commission Grants Orphan Drug Designation to ..
08/08 ALEXION PHARMACEUTICALS INC : Other Events (form 8-K)
07/29 ALEXION PHARMACEUTICALS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL COND..
07/28DJU.S. HOT STOCKS : Hot Stocks to Watch
07/28 ALEXION PHARMACEUTICALS INC : Results of Operations and Financial Condition, Fin..
07/28DJALEXION PHARMACEUTICALS : Cuts Profit Guidance
More news
Sector news : Biopharmaceuticals
09/27DJPFIZER : Scraps Plan to Break Up Company -- WSJ
09/26DJMYLAN : EpiPen Pretax Profits 60% Higher Than Number Told to Congress -- 3rd Upd..
09/26 MYLAN : faces scrutiny over EpiPen profit data shown to Congress
09/26DJPFIZER : Throws Out Plan to Split Into Two Companies -- 2nd Update
09/26DJPfizer Throws Out Plan to Split Into Two Companies
More sector news : Biopharmaceuticals
News from SeekingAlpha
09/23 Priority Review Vouchers Revisited
09/21 Understanding Our Investing Biases - Part 2
09/19 Sarepta to charge $300K for yearly course of Exondys 51
09/14 With Sepsis Trial Done, InflaRx Turns To Heart Surgery
09/08 High Growth - Low Return? Try These Potential Performance Boosters
Advertisement
Chart ALEXION PHARMACEUTICALS, I
Duration : Period :
Alexion Pharmaceuticals, I Technical Analysis Chart | ALXN | US0153511094 | 4-Traders
Full-screen chart
Technical analysis trends ALEXION PHARMACEU...
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Average target price 164 $
Spread / Average Target 30%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
David L. Hallal Chief Executive Officer & Director
Leonard Bell Chairman
Julie O'Neill Executive Vice President-Global Operations
Vikas Sinha Chief Financial Officer & Executive Vice President
Martin MacKay Executive VP, Global Head-Research & Development
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ALEXION PHARMACEUTICAL..-33.96%27 921
CSL LIMITED0.75%36 887
GRIFOLS SA-9.50%13 373
3SBIO INC-21.30%2 785
JIANGXI BOYA BIO-PHARM..--.--%2 526
ABCAM PLC25.26%2 208
More Results